| Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 2.45 k | 2.45 k | 2.45 k | 2.45 k | 2.45 k | |
| Cash burn (monthly) | 10.97 k | 24.35 k | 426.33 k | 180.24 k | 26.30 k | |
| Cash used (since last report) | 208.74 k | 463.30 k | 8.11 mm | 3.43 mm | 500.34 k | |
| Cash remaining | -206.28 k | -460.84 k | -8.11 mm | -3.43 mm | -497.89 k | |
| Runway (months of cash) | -18.8 | -18.9 | -19.0 | -19.0 | -18.9 | |
| 13F holders | Current |
|---|---|
| Total holders | 48 |
| Opened positions | 4 |
| Closed positions | 3 |
| Increased positions | 5 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 565.57 mm |
| Total shares | 17.63 mm |
| Total puts | 0.00 |
| Total calls | 214.21 k |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BioPlus Sponsor | 6.63 mm | $70.15 mm |
| Fitzgerald Securities Cantor | 1.60 mm | $0.00 |
| Periscope Capital | 867.07 k | $48.56 mm |
| Saba Capital Management | 756.25 k | $52.71 mm |
| Polar Asset Management Partners | 601.93 k | $33.71 mm |
| Shaolin Capital Management | 525.00 k | $29.00 k |
| Cowen And | 522.10 k | $29.24 mm |
| Linden Advisors | 500.00 k | $34.85 mm |
| Calamos Advisors | 500.00 k | $28.00 mm |
| GS The Goldman Sachs Group, Inc. | 412.55 k | $23.10 mm |
